Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly…

Continue Reading

News Source: medicalxpress.com